Who Owns Chemtrade Company?

Chemtrade Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Owns Chemtrade Company?

Understanding a company's ownership structure is crucial for investors and strategists alike. Chemtrade, a key player in the industrial chemicals sector, offers a compelling case study in how ownership evolves and impacts corporate strategy. From its IPO in 2001 to its current standing, the story of Chemtrade's ownership reveals much about its trajectory.

Chemtrade's journey, from its origins as a subsidiary to its current status as a publicly traded entity, showcases the dynamic nature of corporate ownership. Knowing who the Chemtrade SWOT Analysis will help you understand the Chemtrade ownership structure, including its major Chemtrade shareholders, is essential for anyone evaluating the Chemtrade stock or analyzing the company's long-term prospects. This exploration will uncover the key players shaping Chemtrade's future.

The Chemtrade Logistics Income Fund, now known as Chemtrade, was established in 2001. The company's formation was spearheaded by David Bookbinder, marking the beginning of its journey in the chemical industry.

The initial strategy involved acquiring the eastern North American sulphur removal businesses from Marsulex Inc. and its subsidiary, BCT Chemtrade Corporation. This strategic move set the stage for Chemtrade's expansion and market presence.

The acquisition was valued at $156 million, with financing secured through a combination of an initial public offering (IPO), exchangeable shares, and a banking facility. The IPO played a crucial role in establishing the company's early ownership structure, transitioning it from a subsidiary to a publicly held trust.

Founding and Initial Acquisition

David Bookbinder founded the company in 2001. The initial acquisition focused on sulphur removal businesses.

Financing Strategy

The acquisition was financed through an IPO, exchangeable shares, and a bank facility. The IPO raised $119 million.

Early Ownership

The IPO established the early ownership structure. Chemtrade transitioned to a publicly held trust.

Initial Public Offering (IPO)

The IPO occurred on July 18, 2001. The IPO raised $119 million.

Key Financials

The initial acquisition cost was $156 million. The IPO provided a significant capital injection.

Early Backers

The IPO indicates a broad distribution of units to public investors. The Bank of Nova Scotia and CIBC co-led the bank facility.

Key Takeaways on Chemtrade Ownership

The initial ownership structure of Chemtrade was established through an IPO, which raised a substantial amount of capital. This IPO allowed for a broad distribution of units, transforming the company into a publicly held trust. For further insights, explore the Brief History of Chemtrade.

• David Bookbinder founded Chemtrade in 2001.
• The initial acquisition was for $156 million.
• The IPO on July 18, 2001, raised $119 million.
• The IPO established the early ownership structure.

Chemtrade SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The evolution of Chemtrade's ownership began with its initial public offering (IPO) on July 18, 2001. Since then, the Chemtrade company has been publicly traded, with its ownership primarily held by institutional investors, mutual funds, and individual shareholders. The Chemtrade company's journey reflects its growth and adaptation within the chemical industry, shaped by market dynamics and strategic decisions.

As a publicly traded entity, Chemtrade's ownership structure is dynamic. The Chemtrade parent company's shares are influenced by investor sentiment and market performance. The Chemtrade stock price has seen fluctuations, with the price at CA$11.20 per share as of May 26, 2025, which is an increase of 21.87% from May 27, 2024, when the price was CA$9.19 per share. This reflects the ongoing interest and confidence in the Chemtrade company.

The major stakeholders in Chemtrade include institutional investors such as Fidelity Central Investment Portfolios LLC - Fidelity International Equity Central Fund, Schwab Fundamental International Small Company Index ETF (FNDC), and iShares Edge MSCI Multifactor Intl Small-Cap ETF (ISCF). As of May 26, 2025, there were 8 institutional owners and shareholders that had filed 13D/G or 13F forms with the SEC, collectively holding a total of 1,820,580 shares. Other notable shareholders include Arrow Capital Management, Inc., Barrantagh Investment Management, Inc., and Matco Financial, Inc. These investors play a crucial role in the company's strategic direction. Further insights into the Chemtrade's financial strategy can be found in the Marketing Strategy of Chemtrade.

Key Highlights of Chemtrade Ownership

Chemtrade's ownership structure is primarily composed of institutional investors and individual shareholders.

• The IPO occurred on July 18, 2001.
• The market capitalization was approximately CA$1.28 billion as of May 30, 2025.
• The share price increased to CA$11.20 per share as of May 26, 2025.
• The net debt to LTM Adjusted EBITDA ratio was 1.98 as of March 31, 2025, reflecting a strong balance sheet.

Chemtrade PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The current board of trustees for the Chemtrade Logistics Income Fund includes Douglas Muzyka, who serves as the Independent Chairman. Other key members include Scott Rook, the CEO, President & Trustee, and independent trustees such as Lucio Di Clemente, Daniella Dimitrov, Luc Doyon, Gary Merasty, Emily Moore, and Suzann Pennington. Scott Rook is the only board member who is not independent, holding the position of CEO within the Fund. Gary Merasty joined the board in February 2024.

This structure reflects a focus on independent oversight, with a majority of the board members being independent trustees. This composition is designed to ensure balanced decision-making and effective governance for the company. Understanding the board's composition is crucial for anyone interested in Chemtrade ownership and its strategic direction.

Chemtrade's voting structure is straightforward, with a one unit, one vote system. As of December 31, 2024, there were 119,010,732 units outstanding. The Declaration of Trust, last amended on January 22, 2024, governs the Fund's operations. At the annual meeting on May 13, 2025, 37,463,472 units, representing 32.24% of the outstanding units, were voted by proxy. All nominated trustees received strong approval; for example, Douglas Muzyka received 98.51% of votes for, and Scott Rook received 98.59% of votes for. There have been no recent proxy battles or significant activist investor campaigns. For more information on the company's growth strategy, you can read about the Growth Strategy of Chemtrade.

Key Takeaways on Chemtrade's Governance

The board is structured to ensure independent oversight, with a majority of independent trustees.

• The voting structure is simple: one unit equals one vote.
• Unitholders consistently approve the Fund's approach to executive compensation.
• Strong support for board members reflects confidence in the company's direction.
• Understanding the board and voting dynamics is crucial for Chemtrade shareholders.

Chemtrade Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the past few years, there have been significant developments impacting the ownership profile of the Chemtrade company. A key initiative has been the Normal Course Issuer Bid (NCIB), initiated in June 2024, which authorized the repurchase of up to approximately 11.7 million units, representing 9.96% of its issued share capital. As of December 31, 2024, around 5.1 million units were repurchased under this NCIB, representing approximately 4% of outstanding units. Chemtrade continued repurchasing units in early 2025, acquiring approximately 3.9 million units in the first quarter and reaching 10.4 million units as of May 9, 2025. The company intends to renew its NCIB, subject to regulatory approval, signaling ongoing efforts to manage its capital structure and potentially increase shareholder value.

In addition to the NCIB, Chemtrade has focused on debt optimization. This included a substantial issuer bid (SIB) for its 2020 8.50% debentures and the subsequent redemption of the remaining debentures in 2024. Furthermore, Chemtrade issued $250 million aggregate principal amount of 6.375% Senior Unsecured Notes due August 28, 2029, in August 2024, followed by an additional $125 million in January 2025. These actions demonstrate a strategic approach to managing the company's financial health and reducing its indebtedness. These changes are important for understanding the Chemtrade ownership structure and its future direction.

From a leadership perspective, Scott Rook has been the President, Chief Executive Officer, and Trustee since March 1, 2021. Insider buying, such as that by Timothy Montgomery in April 2025, indicates confidence in the company's prospects. Chemtrade also increased its monthly distribution rate in January 2025 by approximately 5% to $0.0575 per unit, with a payout ratio of 37% for the twelve months ended March 31, 2025. The company's Vision 2030 Strategic Roadmap, announced in May 2025, and the 2025 Adjusted EBITDA guidance, ranging between $430.0 million and $460.0 million, suggest a positive outlook. For more detailed information, you can explore Revenue Streams & Business Model of Chemtrade.

Who is the CEO of Chemtrade?

Scott Rook has served as President, Chief Executive Officer, and Trustee since March 1, 2021, leading the company's strategic initiatives and financial performance.

What is Chemtrade's stock ticker symbol?

The Chemtrade stock ticker symbol is not provided, but this information can be found on financial websites.

What is Chemtrade's 2025 Adjusted EBITDA guidance?

Chemtrade provided 2025 Adjusted EBITDA guidance ranging between $430.0 million and $460.0 million, indicating positive financial expectations.

What is Chemtrade's Net debt to Adjusted EBITDA target?

Chemtrade expects to end 2025 with a Net debt to Adjusted EBITDA ratio close to 2x, reflecting its debt management strategy.

Chemtrade Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs